ICD Pharma
Cannabinoid Products
Health Tech & Life Sciences
Non Active, Jan 2024 ceased to operate
Company Overview
Snapshot
Founded in April 2017 by Eran Tor, Doron Friedman, and Eran Perry, ICD Pharma was a clinical-stage pharmaceutical company operating with 1–10 employees. The company ceased operations in January 2024.
Business overview
ICD Pharma was a clinical-stage pharmaceutical company focused on developing cannabis-based therapies. The company's core technology involved a portfolio of proprietary pharmaceutical delivery technologies for oral and topical cannabinoid-based products. It aimed to serve the medical cannabis market and pursue clinical development for FDA-approved drugs, operating within the Health Tech & Life Sciences sector, specifically targeting Pharma & Medical Biotechnology and Medical Cannabis segments.
Log in to access full profile ›Company Intelligence Q&A
- What was ICD Pharma's primary focus?
- ICD Pharma was a clinical-stage pharmaceutical company dedicated to developing cannabis-based therapies for medical cannabis products and future FDA-approved drugs.
- When was ICD Pharma founded?
- ICD Pharma was founded in April 2017.
- What was the operational status of ICD Pharma?
- ICD Pharma ceased to operate in January 2024, transitioning to a non-active status.
- Who were the founders of ICD Pharma?
- ICD Pharma was co-founded by Eran Tor, Doron Friedman, and Eran Perry.
- What type of products did ICD Pharma develop?
- ICD Pharma developed oral and topical cannabinoid-based products, utilizing proprietary pharmaceutical delivery technologies.